Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers

GEO MEDICAL CARE PC

NPI: 1487655031 · BROOKLYN, NY 11226 · Internal Medicine Physician · NPI assigned 08/04/2005

$9.79M
Total Medicaid Paid
340,126
Total Claims
312,919
Beneficiaries
84
Codes Billed
2018-01
First Month
2024-12
Last Month

Provider Details

Authorized OfficialKHAN, NASRULLAH (OWNER)
NPI Enumeration Date08/04/2005

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2018 42,865 $1.21M
2019 50,531 $1.28M
2020 35,564 $881K
2021 50,609 $1.06M
2022 62,544 $1.79M
2023 47,462 $1.74M
2024 50,551 $1.83M

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
99213 Office or other outpatient visit for the evaluation and management of an established patient, low complexity 74,474 60,829 $4.90M
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward 18,045 16,509 $729K
99214 Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 6,081 5,801 $598K
90460 Immunization administration through 18 years of age via any route, first or only component 19,285 18,897 $564K
87637 Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV 3,159 3,039 $355K
99393 Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) 6,267 6,222 $346K
G0447 Face-to-face behavioral counseling for obesity, 15 minutes 17,245 16,473 $323K
99394 Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) 5,016 4,972 $298K
99392 Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) 4,461 4,370 $230K
99188 10,256 10,216 $168K
99441 4,506 4,169 $159K
99391 Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) 2,190 2,132 $128K
99395 Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years 1,679 1,654 $120K
92551 15,292 15,230 $113K
90461 4,048 3,991 $93K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A 9,146 8,736 $79K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe 1,568 1,475 $59K
99051 18,549 17,086 $57K
G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) 4,186 3,467 $47K
83655 4,855 4,759 $45K
94010 1,204 1,125 $36K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type 2,346 1,501 $33K
92567 2,411 2,277 $32K
99203 Office or other outpatient visit for the evaluation and management of a new patient, low complexity 354 353 $31K
H0005 Alcohol and/or drug services; group counseling by a clinician 4,441 4,435 $23K
99050 4,230 4,044 $22K
99177 11,204 11,166 $14K
36415 Collection of venous blood by venipuncture 13,180 12,815 $14K
99396 Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years 154 149 $14K
99406 3,918 3,910 $13K
0001A 425 419 $13K
0072A 322 322 $12K
0002A 386 385 $12K
96110 Developmental screening, with scoring and documentation, per standardized instrument 3,195 3,182 $11K
0071A 285 284 $10K
90658 4,300 4,254 $10K
G0444 Annual depression screening, 5 to 15 minutes 5,170 5,156 $8K
99401 1,078 1,028 $7K
99072 23,519 18,936 $7K
92552 225 225 $6K
87426 Infectious agent antigen detection, SARS-CoV-2 (COVID-19) 192 189 $6K
99381 53 53 $4K
99215 Prolong outpt/office vis 31 28 $4K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 212 203 $4K
0003A 98 98 $4K
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine 270 259 $4K
94060 54 54 $3K
90677 361 360 $2K
90651 973 971 $2K
90716 1,089 1,081 $2K
90715 384 384 $1K
90707 1,121 1,112 $1K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction 131 128 $1K
90656 325 324 $1K
90674 174 174 $825.43
90480 29 29 $632.19
99211 Office or other outpatient visit for the evaluation and management of an established patient, minimal severity 38 38 $558.49
0124A 15 15 $550.13
69210 14 12 $363.76
99174 863 851 $361.43
99173 801 795 $338.40
90474 43 43 $300.18
92570 14 14 $297.22
90734 796 794 $277.75
86580 28 27 $244.57
90633 1,134 1,125 $141.89
97802 43 40 $137.92
A7003 Administration set, with small volume nonfiltered pneumatic nebulizer, disposable 148 145 $133.08
A7014 Filter, nondisposable, used with aerosol compressor or ultrasonic generator 143 140 $92.44
90672 301 300 $82.61
90657 674 668 $56.40
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 105 105 $50.00
A7015 Aerosol mask, used with dme nebulizer 109 106 $43.66
90648 1,336 1,330 $35.95
90670 1,307 1,300 $17.99
91300 611 555 $6.78
90700 707 704 $0.43
91307 599 552 $0.17
90723 820 815 $0.15
90713 384 384 $0.09
90686 278 278 $0.08
90680 767 762 $0.07
3023F 56 53 $0.00
99000 9,840 9,528 $0.00